XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Summary Description of the Company (Details Narrative) - USD ($)
Oct. 14, 2021
Oct. 13, 2021
Oct. 06, 2021
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Common stock, shares issued         14,114,707 14,114,707
Common stock, shares outstanding         14,114,707 14,114,707
Common stock, shares authorized         100,000,000 100,000,000
Stock split, description     1.411-to-1.0      
Offering costs       $ 0 $ 0  
Subsequent Event [Member]            
Common stock, shares authorized     100,000,000.0      
Stock split, description     1.411-to-1.0      
Subsequent Event [Member] | IPO [Member]            
Stock issued during period, shares 5,000,000.0          
Sale of stock, price per share $ 14.00          
Proceeds from issuance of initial publoc offering $ 70,000,000.0          
Underwriting fees 4,900,000          
Offering costs $ 700,000          
Subsequent Event [Member] | Senior Notes [Member]            
Debt conversion, shares issued upon conversion   15,803,200        
Debt conversion, original debt amount   $ 22,400,000        
PAVmed Inc. [Member]            
Shares outstanding         11,552,562 11,552,562
Parent Company [Member] | Subsequent Event [Member] | IPO [Member]            
Stock issued during period, shares 571,428